Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.075
Bid: 1.00
Ask: 1.15
Change: 0.083 (7.90%)
Spread: 0.15 (15.00%)
Open: 1.05
High: 1.133
Low: 1.133
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing, Issue of Equity and TVR

14 Feb 2022 07:00

RNS Number : 5108B
Microsaic Systems plc
14 February 2022
 

14 February 2022

 

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Director Dealing, Issue of Equity and Total Voting Rights

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, announces that it will issue 85,000,000 ordinary shares in the Company (the "Fee Shares") to certain of the Company's directors in respect of their annual remuneration for their second year of service, paid in advance, as outlined in the Company's announcement of 19 January 2021.

 

In addition, the Company received notice from Dr Nigel Burton, Non-Executive Director of the Company of his intention to exercise warrants ("Warrants") relating to 200,000,000 ordinary shares, reflecting an investment of £200,000 in the Company. The Warrants were granted in conjunction with the fundraise completed by the Company in February 2021 (the "Fundraise") at an exercise price of 0.1p, being the Fundraise issue price.

 

Gerry Brandon, Non-executive Chairman of Microsaic Systems, commented:

"The exercise of warrants and investment of £200,000 by Dr. Nigel Burton, Non-executive Director, and our receipt of share based remuneration in lieu of our respective salaries for the second year, represent a strong signal of our full support for Microsaic and the commercial potential to come from its under-exploited technology. It also reflects our continuing belief in the quality of the Microsaic team, whose capabilities and expertise continue to impress."

 

Application has been made to the London Stock Exchange for 285,000,000 ordinary shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 am. on or around 17 February 2022.

 

Director

Position

Annual Remuneration

Number of Fee Shares to be issued

Number of Ordinary Shares issued pursuant to Warrants exercised

Number of Ordinary Shares held on Admission

% of issued share capital held on Admission

Gerard Brandon

Non-Executive Chairman

£50,000

50,000,000

-

190,000,000

2.99

Nigel Burton

Non-Executive Director

£35,000

35,000,000

200,000,000

300,500,000

4.72

 

Total voting rights

 

Following Admission, the Company will have 6,361,365,146 ordinary shares in issue. The Company does not hold any shares in treasury. Therefore, from Admission, the total voting rights in the Company will be 6,361,365,146.

 

From Admission, the figure of 6,361,365,146 may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic

 

Microsaic develops and commercialises globally micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need: whether within a human health environment; conventional laboratory setting; within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow; or in front-line environmental monitoring.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

Details of the person discharging managerial responsibilities / person closely associated

a) 

Name

Gerard Brandon

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares in lieu of annual remuneration (Fee Shares)

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

50,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Dr Nigel Burton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares in lieu of annual remuneration (Fee Shares)

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

35,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Dr Nigel Burton

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Microsaic Systems plc

b)

LEI

213800P1VXZSD3US5N79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.01 pence each

 

 

GB00B547ZY09

b)

Nature of the transaction 

Issue of Ordinary Shares pursuant to exercise of warrants

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1 pence

200,000,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Not applicable

 

 

e)

Date of the transaction

11 February 2022

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUACPUPPPGW
Date   Source Headline
30th May 20141:09 pmRNSNotification of Major Interest in Shares
6th May 201411:58 amRNSGRANT OF SHARE OPTIONS
30th Apr 20147:00 amRNSPreliminary Results
28th Apr 201412:33 pmRNSNotification of Major Interest in Shares
23rd Apr 20148:18 amRNSNotification of Major Interest in Shares
17th Apr 20149:19 amRNSHolding(s) in Company
15th Apr 20149:17 amRNSAppointment of Finance Director
14th Apr 20149:42 amRNSRe Agreement
11th Dec 20133:56 pmRNSHolding(s) in Company
21st Oct 20137:00 amRNSFormation of new Scientific Advisory Group
27th Sep 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSAppointment of Chairman
24th Jun 20137:00 amRNSIssue of Equity
4th Jun 20135:08 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSMicrosaic welcomes launch of the IsoleraT Dalton
31st May 201310:28 amRNSHolding(s) in Company
28th May 20132:44 pmRNSHolding(s) in Company
24th May 201311:23 amRNSResults of General Meeting
15th May 201311:23 amRNSResults of Annual General Meeting
7th May 20134:35 pmRNSDistribution of Circular of General Meeting
3rd May 20136:25 pmRNSConditional Placing to Raise up to £4.28 million
22nd Apr 20137:00 amRNSDistribution of Annual Report and Accounts
15th Apr 20137:00 amRNSPreliminary Results
10th Apr 20137:00 amRNSSigning of commercial agreement
15th Mar 20131:05 pmRNSHolding(s) in Company
14th Mar 20139:00 amRNSLaunch New Chip-based Mass Spectrometry Instrument
12th Dec 20129:36 amRNSGrant of Share Options
19th Oct 20124:45 pmRNSDirector/PDMR Shareholding
15th Oct 20122:26 pmRNSDirector/PDMR Shareholding
24th Sep 20127:00 amRNSAppointment of new CEO
24th Sep 20127:00 amRNSInterim Results
4th Sep 201210:00 amRNSAgreement
4th Jul 20129:46 amRNSGrant of Share Options
25th Jun 201210:29 amRNSMicrosaic Wins R&D100 Award
8th Jun 201210:53 amRNSHolding(s) in Company
7th Jun 20127:00 amRNSHolding(s) in Company
30th May 20123:40 pmRNSHolding(s) in Company
30th May 201211:36 amRNSAGM Results
29th May 201210:35 amRNSHolding(s) in Company
29th May 20127:00 amRNSPlacing
11th May 20129:18 amRNSHolding(s) in Company
9th May 20127:00 amRNSRe Agreement
30th Apr 20122:22 pmRNSDistribution of Annual Report and Accounts
25th Apr 20127:00 amRNSPreliminary Results
18th Apr 201210:07 amRNSMicrosaic Exhibits at Analytica 2012
22nd Feb 201211:21 amRNSHolding(s) in Company
12th Dec 20117:00 amRNSDirectorate Change
25th Nov 20119:04 amRNSExercise of Share Options
2nd Nov 20118:59 amRNSHolding(s) in Company
5th Oct 20119:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.